Rafarma Pharmaceuticals, Inc. (RAFA)

Rafarma Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2012	FY 2011
Period Ending	Jun 29, 2026	Mar 31, 2012	Mar 31, 2011
Debt / Equity Ratio	0.00	0.00	0.11
Net Debt / Equity Ratio	0	0	0.07
Asset Turnover	0.00	0.00	-
Inventory Turnover	0.64	0.64	-
Return on Equity (ROE)	-0.07%	-0.07%	-
Return on Assets (ROA)	-0.04%	-0.04%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2012

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every year for this company.

Update frequency:

Yearly

Last checked:

Jul 3, 2026

Data Sources Report a data error